Key result
Dantrolene sodium is the only known specific drug for the treatment and prophylaxis of malignant hyperthermia, a rare and potentially fatal hypermetabolic syndrome.
Population
Individuals susceptible to malignant hyperthermia
Design
Review
Loading...
Dantrolene remains essential for malignant hyperthermia; confirms its singular role while leaving open development of additional agents.
Provides a comprehensive overview of malignant hyperthermia, emphasizing stress as a potential trigger and dantrolene sodium as the specific treatment.
A 2016 study conducted a review in Malignant hyperthermia. Dantrolene sodium was evaluated. Dantrolene sodium is the only known specific drug for the treatment and prophylaxis of malignant hyperthermia, a rare and potentially fatal hypermetabolic syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: